Fluvoxamine was the FIRST successful specific serotonine-reuptake-blocker(SSRI)to stand the test of time.
Fluvoxamine is a Duphar product.
Fluvoxamine is a TYPICAL serotonine-reuptake-blocker,as opposed to fluoxetine which is an atypical serotonine-reuptake-blocker.
Typical and atypical SSRIs are distinguished by the following properties:
Fluvoxamine is the prototype of the typical SSRIs.
Typical SSRIs are thought to act by diminishing dopaminergic neurotransmission via serotoninergic mechanisms.
Fluoxetine is the prototype of an atypical SSRI.
Fluoxetine is thought to act by increasing dopaminergic neurotransmission via indirect stimulation of serotoninergic 5-HT2A receptors.
In a way,fluoxetine is a very mild hallucinogen.
Insomnia and headaches induced by a dose of 2O mgr of fluoxetine are promptly antagonised by an equipotent dose of IOO mgr of fluvoxamine.
Subhallucinations induced by fluoxetine are,also,efficiently blocked by fluvoxamine.
I,incidentally,discovered the interesting properties of fluvoxamine against the effects of jet-lag!
If you take a IOO mgr dose of fluvoxamine let say one hour before the departure to a far away country you arrive fresh at your destination without experiencing jet-lag.
I have been using fluvoxamine to that effect since its introduction in Switzerland,a long time ago!
So I would like to encourage researchers to explore the anti jet-lag effects of fluvoxamine.